Direct Oral Anticoagulants for Atrial Fibrillation in Patients Receiving Hemodialysis: A Review and Discussion of Evidence

Cardiology in Review · Published 2026-08-03 · DOI 10.1097/crd.0000000000001417

Authors (3)

Patrick Kohn, Danielle Garcia, Angela Cheng-Lai

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Kohn, P., Garcia, D., Cheng-Lai, A. (2026). Direct Oral Anticoagulants for Atrial Fibrillation in Patients Receiving Hemodialysis: A Review and Discussion of Evidence. Cardiology in Review. https://doi.org/10.1097/crd.0000000000001417

Related articles

• Exosome Therapy: A Novel Investigational Approach in Acute Myocardial Infarction · Cardiology in Review · 2026 · Same journal
• Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection · Cardiology in Review · 2026 · Same journal
• Women in Heart Failure With Preserved Ejection Fraction Clinical Trials: Bridging the Gap Between Trial Enrollment and Real-World Disease Burden · Cardiology in Review · 2026 · Same journal
• Anesthetic-Electrophysiologic Interactions: How Sedatives Shape Cardiac Conduction and Arrhythmia Risk · Cardiology in Review · 2026 · Same journal
• Cardiopulmonary Manifestations of Systemic Sclerosis: Pathophysiology, Clinical Presentation, and Management · Cardiology in Review · 2026 · Same journal
• Growing Heart Valves in Congenital Cardiac Surgery: Mechanisms and Considerations for Tissue-Engineered Heart Valves, Noncryopreserved Homografts, and Partial Heart Transplantation · Cardiology in Review · 2026 · Same journal
• Impella Outcomes in Acute Myocardial Infarction Versus Non–Acute Myocardial Infarction Cardiogenic Shock: A United States Nationwide Propensity-Matched Analysis (2016–2022) · Cardiology in Review · 2026 · Same journal
• Chocolate and Cardiovascular Disease · Cardiology in Review · 2026 · Same journal
• Pulmonary Hypertension and Kidney Disease: A Review of a High-Risk Patient Population · Cardiology in Review · 2026 · Same journal
• Ranolazine: An Antiarrhythmic and Cardioprotective Agent · Cardiology in Review · 2026 · Same journal